Publication: A brand-new cardiorenal syndrome in the Coronavirus Disease- 2019 (COVID-19) setting
dc.contributor.coauthor | Apetrii, Mugurel | |
dc.contributor.coauthor | Enache, Stefana | |
dc.contributor.coauthor | Siriopol, Dimitrie | |
dc.contributor.coauthor | Burlacu, Alexandru | |
dc.contributor.coauthor | Kanbay, Asiye | |
dc.contributor.coauthor | Scripcariu, Dragos | |
dc.contributor.coauthor | Covic, Adrian | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Kanbay, Mehmet | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T11:37:52Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Coronaviruses are a major pathogen for adults, causing up to one-third of community-acquired respiratory tract infections in adults during epidemics. Although the pandemic outbreak of coronavirus disease-2019 (COVID-19) targets preferentially patient’s lungs, recent data have documented that COVID-19 causes myocarditis, acute myocardial infarction, exacerbation of heart failure and acute kidney injury. Studies show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to its predecessor SARS-CoV, engages angiotensin-converting enzyme 2 (ACE2) as the entry receptor. ACE2 is also expressed in the heart, providing a link between coronaviruses and the cardiovascular system. | |
dc.description.fulltext | YES | |
dc.description.indexedby | PubMed | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | N/A | |
dc.description.version | Publisher version | |
dc.identifier.doi | 10.1093/ckj/sfaa082 | |
dc.identifier.eissn | 2048-8513 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR02264 | |
dc.identifier.issn | 2048-8505 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85097461364 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/71 | |
dc.keywords | ACE2 | |
dc.keywords | Cardiorenal syndrome | |
dc.keywords | CKD | |
dc.keywords | COVID-19 | |
dc.keywords | Myocardial injury | |
dc.language.iso | eng | |
dc.publisher | Oxford University Press (OUP) | |
dc.relation.grantno | NA | |
dc.relation.ispartof | Clinical Kidney Journal | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8909 | |
dc.subject | Medicine | |
dc.title | A brand-new cardiorenal syndrome in the Coronavirus Disease- 2019 (COVID-19) setting | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Kanbay, Mehmet | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
Files
Original bundle
1 - 1 of 1